Results 91 to 100 of about 6,081 (166)

MIF inhibition attenuates proliferative vitreoretinopathy pathogenesis and protects the eye in preclinical model. [PDF]

Biomed Pharmacother
Hamadmad S, Heisler-Taylor T, Summitt D, Shalash R, Zatari A, Martini D, Sohail M, Racine J, Xie Z, Hill K, Phelps M, Cebulla CM.   +11 more
europepmc   +1 more source

Subretinal fluid in rhegmatogenous retinal detachment: potential biomarkers and therapeutic targets for proliferative vitreoretinopathy. [PDF]

Int J Ophthalmol
Mao YS, Yu WH.
europepmc   +1 more source

LARGE-SIZED HUMAN AMNIOTIC MEMBRANE PATCHING-ASSISTED VITRECTOMY FOR THE MANAGEMENT OF POSTOPERATIVE PROLIFERATIVE VITREORETINOPATHY IN COMPLEX RHEGMATOGENOUS RETINAL DETACHMENTS. [PDF]

Retina
Gu R, Wu K, Zhang W, Jiang R, Xu G, Sun Z.   +5 more
europepmc   +1 more source

Non-surgical interventions for proliferative vitreoretinopathy-a systematic review. [PDF]

Eye (Lond)
Hunter G, Maclean N, Watson S, Colyer M, Leong J, Agrawal R, McClellan SF, Miller KE, Woreta FA, Caldwell MC, Williamson T, Gensheimer W, Cavuoto K, Hoskin AK, Rousselot Ascarza A, Dhawahir-Scala WGF, Sundar G, Mazzoli RA, Shah P, Woodcock M, Kuhn F, Gomes RS, Justin GA, Blanch RJ.   +23 more
europepmc   +1 more source

Effect of 3',4'-Dihydroxyflavonol Eye Drops in a Rat Model of Dispase-Induced Proliferative Vitreoretinopathy. [PDF]

Antioxidants (Basel)
Chan EC, Zeng C, Luu CD, Abbott CJ, Chan NT, Datta KK, Williamson N, Allen PJ, Fan Gaskin JC.   +8 more
europepmc   +1 more source

From fibrotic mechanisms to clinical translation: the drug therapy revolution and delivery system breakthrough in proliferative vitreoretinopathy. [PDF]

Front Immunol
Chen Z, Liu J, Quan L, Wu L, Xu Q.
europepmc   +1 more source

Removal of subretinal proliferative vitreoretinopathy: case series and literature review. [PDF]

Int J Retina Vitreous
Silpa-Archa S, Lalitwongsa P.
europepmc   +1 more source

Vaccinia-related kinase 1/snail family transcriptional repressor 1 regulates epithelial-mesenchymal transition and inflammation in proliferative vitreoretinopathy. [PDF]

Int J Ophthalmol
Ying Y, Liao X.
europepmc   +1 more source

A multicenter study on rates and risk factors of proliferative vitreoretinopathy in a low-income economy. [PDF]

PLoS One
Okonkwo ON, Udoh MM, Adenuga O, Ovienria W, Ibanga A, Nkanga D, Oyekunle I, Akanbi T, Agweye C.   +8 more
europepmc   +1 more source

Evaluation of serum YKL-40 and Galectin-3 as predictive biomarkers for proliferative vitreoretinopathy in rhegmatogenous retinal detachment: a prospective comparative study. [PDF]

BMC Ophthalmol
Koçak N, Özdemir A, Esenkaya M.
europepmc   +1 more source